Search

3i Group PLC

Abrir

SetorÍndices

3,358 -4.03

Visão Geral

Variação de preço das ações

24h

Atual

Mín

3350

Máximo

3542

Indicadores-chave

By Trading Economics

Rendimento

297M

3.3B

Vendas

-1.4B

192M

P/E

Médio do Setor

4.821

16.711

EPS

3.4

Rendimento de Dividendos

2.4

Margem de lucro

1,711.979

Funcionários

223

EBITDA

-244M

2.8B

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+31.83% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

2.40%

6.35%

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-641M

31B

Abertura anterior

3362.03

Fecho anterior

3358

Sentimento de Notícias

By Acuity

35%

65%

7 / 26 Ranking em Indices

3i Group PLC Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

29 de jan. de 2026, 16:27 UTC

Grandes Movimentos do Mercado

U.K. Private Equity Group 3i's Shares Surge on Strong Sales at Key Asset

13 de nov. de 2025, 10:02 UTC

Ganhos
Grandes Movimentos do Mercado

3i Group Shares Tumble After Cautious Outlook

29 de jan. de 2026, 14:18 UTC

Conversa de Mercado
Ganhos

3i Group's Value Proposition Built on Discount Retailer -- Market Talk

29 de jan. de 2026, 08:47 UTC

Conversa de Mercado
Ganhos

3i Faces Tough Conditions in France, Competition from Chinese E-Tailers -- Market Talk

29 de jan. de 2026, 07:06 UTC

Ganhos

3i Group Gross Cash at Dec. 31 GBP995M

29 de jan. de 2026, 07:04 UTC

Ganhos

3i Group: Action Gross Cash at Dec. 31 Was EUR807M

29 de jan. de 2026, 07:02 UTC

Ganhos

3i Group: Action LFL Sales Up 6.1% in First Four Weeks of Jan

29 de jan. de 2026, 07:01 UTC

Ganhos

3i Group: Action's Like-For-Like Sales Growth Was 4.9%

29 de jan. de 2026, 07:01 UTC

Ganhos

3i Group: Action Net Sales, Operating Ebitda Rose 16% and 14%

29 de jan. de 2026, 07:00 UTC

Ganhos

3i Group NAV Per Shr Rose to 3,017 Pence

13 de nov. de 2025, 07:29 UTC

Ganhos

3i Group: First Div Is Set at 50% of Total Div for FY2025

13 de nov. de 2025, 07:29 UTC

Ganhos

3i Group PLC Declares Dividend of 36.5p

13 de nov. de 2025, 07:28 UTC

Ganhos

3i Group Had Net Debt of GBP772M, Gearing of 3%

13 de nov. de 2025, 07:28 UTC

Ganhos

3i Group Ended Period With Liquidity of GBP1.64B

13 de nov. de 2025, 07:26 UTC

Ganhos

3i Group: Several of Other Large Portfolio Companies Are Showing Good Momentum

13 de nov. de 2025, 07:25 UTC

Ganhos

3i Group: Action Continued to Trade Strongly

13 de nov. de 2025, 07:25 UTC

Ganhos

3i Group Private Equity Business Delivered a Gross Investment Return of GBP3.23B

13 de nov. de 2025, 07:25 UTC

Ganhos

3i Group Total Return GBP3.29B, or 13% on Opening Shareholders' Funds

13 de nov. de 2025, 07:12 UTC

Ganhos

3i Group: Action Generated Net Sales of EUR11.23B in Nine Reporting Periods Ending Sep. 28

13 de nov. de 2025, 07:07 UTC

Ganhos

3i Group Private Equity Business Gross Investment Return GBP3.23B

13 de nov. de 2025, 07:07 UTC

Ganhos

3i Group Had Liquidity of GBP1.64B at Sep. 30

13 de nov. de 2025, 07:07 UTC

Ganhos

3i Group Had Net Debt of GBP772M, Gearing of 3%

13 de nov. de 2025, 07:05 UTC

Ganhos

3i Group Raises Dividend to 36.5p Vs 30.5p

13 de nov. de 2025, 07:03 UTC

Ganhos

3i Group: Transaction Market and Wider Environment Likely to Remain Challenging Into Fiscal 2H

13 de nov. de 2025, 07:03 UTC

Ganhos

3i Group: Remain Cautious in Deployment of Capital Into New Investment, Will Continue to Allocate Selectively

13 de nov. de 2025, 07:02 UTC

Ganhos

3i Group 1H NAV/Shr 2,857p

13 de nov. de 2025, 07:02 UTC

Ganhos

3i Group Total Return GBP3.29B

13 de nov. de 2025, 07:00 UTC

Ganhos

3i 1H EPS GBP3.398

13 de nov. de 2025, 07:00 UTC

Ganhos

3i 1H NAV/Shr GBP28.57

2 de set. de 2025, 11:16 UTC

Conversa de Mercado

3i Group Seems to Value Investments Conservatively -- Market Talk

3i Group PLC Previsão

Preço-alvo

By TipRanks

31.83% parte superior

Previsão para 12 meses

Média 4,148.57 GBX  31.83%

Máximo 5,200 GBX

Mínimo 3,000 GBX

Com base em 8 analistas de Wall Street que oferecem metas de preço de 12 meses para 3i Group PLC - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

8 ratings

6

Comprar

0

Manter

2

Vender

Sentimento

By Acuity

7 / 26 Ranking em Índices

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre 3i Group PLC

3i Group plc is a private equity firm specializing in mature companies, growth capital, middle markets, infrastructure, and management leveraged buyouts and buy-ins. The firm also provides infrastructure financing and debt management. For debt management, it invests in senior and mezzanine corporate debt in typically large and private companies in United Kingdom, Europe, Asia, and North America. It makes private equity investments in business and technology services, financial services, consumer, healthcare, consumption and distribution, media and telecom, renewable energy, wind, and industrial technology sector. Within business and technology services, the firm seeks to invest in sub sectors such as testing, inspection and certification; intelligent outsourcing, BPO and consultancy; human capital including staffing, governance, risk and compliance, services to pharmaceutical companies, vertical application software, education and training businesses; facilities management; support services to industrial sectors such as oil and gas and utilities; human resources outsourcing and advising; recruitment; logistics and infrastructure support services including distribution, waste, and rental. In the consumer sector, it focuses on, multi-unit roll out, omni-channel propositions, niche branded consumer goods, polarization, health and wellness, ageing population, millennials, consumer goods; e-commerce; retail; food and drinks; and leisure. In the healthcare sector, the firm focuses on outsourced medical device manufacturing & services, outsourced pharmaceutical manufacturing & services, bioprocessing supply chain, life science tools and diagnostics, wellness & consumer health products, pharmaceuticals and biotechnology including specialty pharma, generics / OTC, drug delivery, and animal health; healthcare Services including activities such as elderly and specialty care, including caring for people in their own homes, in hospital and in community facilities, as well as operational services such as outsourced support, cl
help-icon Live chat